Canada - English - Health Canada

teva canada limited - acebutolol (acebutolol hydrochloride) - tablet - 400mg - acebutolol (acebutolol hydrochloride) 400mg - beta-adrenergic blocking agents

Canada - English - Health Canada

valeant canada lp / valeant canada s.e.c. - famotidine - tablet - 20mg - famotidine 20mg - histamine h2-antagonists

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. information related to usage of rizatriptan benzoate in pediatric patients (6 to 17 years old) is approved for merck & co., inc.’s rizatriptan benzoate tablets. however, due to merck & co., inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric patient (6 to 17 years old) usage information. limitations of use - rizatriptan benzoate tablets  should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablet is administered to treat any subsequent attacks. - rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see contraindications (4)] . - rizatriptan benzoate tablets are not indicat

United States - English - NLM (National Library of Medicine)

a-s medication solutions - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. limitations of use - rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks.  - rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see contraindications (4)] .  - rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks.  - safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache. rizatriptan benzoate is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - propranolol hydrochloride - prolonged release capsules - 80 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - propranolol hydrochloride - prolonged release capsules - 160 milligram

Canada - English - Health Canada

pfizer canada ulc - propranolol hydrochloride - capsule (extended release) - 80mg - propranolol hydrochloride 80mg - beta-adrenergic blocking agents

Canada - English - Health Canada

pfizer canada ulc - propranolol hydrochloride - capsule (extended release) - 120mg - propranolol hydrochloride 120mg - beta-adrenergic blocking agents

Canada - English - Health Canada

pfizer canada ulc - propranolol hydrochloride - capsule (extended release) - 160mg - propranolol hydrochloride 160mg - beta-adrenergic blocking agents

Canada - English - Health Canada

pfizer canada ulc - propranolol hydrochloride - capsule (extended release) - 60mg - propranolol hydrochloride 60mg - beta-adrenergic blocking agents